In a move set to energize scientific discovery, the National Natural Science Foundation of China (NSFC) has announced its Private Enterprise Innovation and Development Joint Fund. This initiative is designed to empower private companies to step up and lead groundbreaking basic research. 🚀
The fund invites private enterprises to identify key research challenges based on their innovation needs and will back top researchers nationwide to tackle these issues. NSFC Director Dou Xiankang highlighted the aim of strengthening the partnership between industry and science by encouraging more investment in foundational research.
The focus is on basic and applied research that aligns with urgent national economic and social development needs. By merging technological innovation with industrial insights, the initiative is expected to drive transformative growth and set new standards for research collaboration.
Already, four major pharmaceutical firms — Hengrui Pharmaceuticals, Mindray Bio-Medical, Singclean Medical, and Qilu Pharmaceutical — have joined as inaugural partners. Their combined expertise is set to break new ground in the medical field and beyond.
This dynamic step marks a significant push towards deep integration of technological innovation and industrial progress. Stay tuned as this exciting venture unfolds and reshapes the future of basic research in China!
Reference(s):
China launches fund to support private companies in basic research
cgtn.com
